US2008161265A1PendingUtilityA1
Use of lactulose in the treatment of autism
Est. expiryAug 30, 2025(expired)· nominal 20-yr term from priority
A61P 43/00A61P 25/00A61P 3/00A61P 1/00A61K 31/7016A61K 31/045A61K 31/7012A61K 31/047
64
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A treatment for autism in which an effective amount of lactulose is administered in order to bind excess ammonia in the gastrointestinal tract, the bloodstream, and the nervous system in order to prevent or reverse ammonia poisoning caused by the administration of certain antibiotics. Lactulose molecules in the colon are fermented by certain bacteria. The fermentation process lowers the colonic pH, and ammonia, in the form of ammonium ions, is used by the bacteria for amino acid and protein synthesis. This lowers the serum ammonia levels and reduces neurotoxicity.
Claims
exact text as granted — not AI-modified1 - 10 . (canceled)
11 . A composition for treating autism and the symptoms thereof in an individual comprising an effective amount of lactulose.
12 . The composition of claim 11 , wherein one of the symptoms is selected from a group consisting of a gastrointestinal disorder, a neurological disorder, and a combination thereof.
13 . The composition of claim 11 , wherein the effective amount of lactulose comprises about 0.4 g/kg lactulose and 0.1 g/kg mannitol per dose.
14 . The composition of claim 11 , wherein the effective amount of lactulose comprises about 0.3 g/kg lactulose per dose.
15 . The composition of claim 11 , wherein the effective amount of lactulose is administered approximately two to five times per day.
16 . The composition of claim 11 , wherein the effective amount of lactulose is manufactured in a form selected from the group consisting of a powder, liquid solution, syrup, and a combination thereof.
17 . The composition of claim 11 , wherein the effective amount of lactulose includes an amount of lactulose sufficient to decrease ammonia levels in the blood of the individual.
18 . The composition of claim 11 , wherein the effective amount of lactulose includes an amount of lactulose sufficient to decrease ammonia levels in the gastrointestinal tract of the individual.
19 . The composition of claim 11 , wherein the effective amount of lactulose includes an amount of lactulose sufficient to decrease ammonia levels in the nervous system of the individual.
20 . The composition of claim 11 , wherein the effective amount of lactulose includes an amount of lactulose sufficient to reverse ammonia poisoning caused by the administration of antibiotics that leave a residue in the gastrointestinal tract of the individual.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.